LU74763A1 - - Google Patents

Info

Publication number
LU74763A1
LU74763A1 LU74763A LU74763A LU74763A1 LU 74763 A1 LU74763 A1 LU 74763A1 LU 74763 A LU74763 A LU 74763A LU 74763 A LU74763 A LU 74763A LU 74763 A1 LU74763 A1 LU 74763A1
Authority
LU
Luxembourg
Application number
LU74763A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU74763A1 publication Critical patent/LU74763A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
LU74763A 1975-04-18 1976-04-14 LU74763A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752517771 DE2517771A1 (de) 1975-04-18 1975-04-18 Neue prostaglandin-acetylen-analoga und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
LU74763A1 true LU74763A1 (fr) 1977-01-12

Family

ID=5944669

Family Applications (1)

Application Number Title Priority Date Filing Date
LU74763A LU74763A1 (fr) 1975-04-18 1976-04-14

Country Status (15)

Country Link
US (1) US4073934A (fr)
JP (1) JPS51131860A (fr)
AT (1) AT360182B (fr)
AU (1) AU510088B2 (fr)
BE (1) BE840872A (fr)
CA (1) CA1079725A (fr)
CH (1) CH626876A5 (fr)
DE (1) DE2517771A1 (fr)
DK (1) DK142976A (fr)
FR (1) FR2307525A1 (fr)
GB (1) GB1549047A (fr)
IE (1) IE43600B1 (fr)
LU (1) LU74763A1 (fr)
NL (1) NL7604016A (fr)
SE (1) SE7604409L (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2517772A1 (de) * 1975-04-18 1976-10-28 Schering Ag Cyclopentanderivate und verfahren zu ihrer herstellung
US4268522A (en) * 1976-06-14 1981-05-19 Pfizer Inc. 13,14-Dihydro-15-alkenyl- and 13,14-dihydro-15-alkynyl prostaglandins and analogs thereof
DE2729960A1 (de) * 1977-06-30 1979-01-18 Schering Ag Neue acetylenprostaglandine und verfahren zu ihrer herstellung
JPS6033429B2 (ja) * 1980-04-28 1985-08-02 小野薬品工業株式会社 プロスタグランジン類似化合物
GB2225573A (en) * 1988-09-16 1990-06-06 Ueno Seiyaku Oyo Kenkyujo Kk 13,14-dihydro-15-keto-PGFs
ES2223141T3 (es) * 1997-09-09 2005-02-16 Duke University Prostaglandinas aromaticas tetrahidro sustituidas por c16?-c20? utilizadas como agonistas fp.
DE69809268T2 (de) * 1997-09-09 2003-08-28 Procter & Gamble Aromatische c16-c20-substituierte tetrahydro-prostaglandine und ihre verwendung als prostaglandin f agonisten
EP1159266B1 (fr) * 1999-03-05 2004-11-03 Duke University Analogues de prostaglandines c-16 fp selectives insaturees
WO2000051977A1 (fr) * 1999-03-05 2000-09-08 The Procter & Gamble Company Intermediaires aldehydes pour l'elaboration de derives des prostaglandines
US6894175B1 (en) * 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US7354190B2 (en) * 2003-10-30 2008-04-08 Deka Products Limited Partnership Two-stage mixing system, apparatus, and method
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
WO2014015246A1 (fr) 2012-07-19 2014-01-23 Cayman Chemical Company, Inc. Compositions de difluorolactame destinées à des maladies et des affections osseuses médiées par ep4
EP2970234B1 (fr) 2013-03-15 2018-07-18 Cayman Chemical Company, Inc. Procédés de synthèse d'un analogue difluorolactam
EP3235817B1 (fr) 2013-03-15 2018-12-12 Cayman Chemical Company, Incorporated Composés de lactamine en tant qu'agonistes sélectifs du récepteur ep4 destinés à être utilisés dans le traitement des maladies et affections transmises par l'ep4
JP2016527006A (ja) 2013-07-19 2016-09-08 ケイマン ケミカル カンパニー， インコーポレーテッド 骨成長を促進するための方法、システム、及び組成物
CN109071427A (zh) 2016-05-09 2018-12-21 Ａｇｃ株式会社 新型的前列腺素衍生物
CA3079807A1 (fr) 2017-10-31 2019-05-09 AGC Inc. Procede de production d'un derive de prostaglandine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50140427A (fr) * 1974-02-27 1975-11-11

Also Published As

Publication number Publication date
DE2517771A1 (de) 1976-10-28
CA1079725A (fr) 1980-06-17
US4073934A (en) 1978-02-14
AU1314876A (en) 1977-10-27
IE43600B1 (en) 1981-04-08
SE7604409L (sv) 1976-10-19
FR2307525A1 (fr) 1976-11-12
AT360182B (de) 1980-12-29
NL7604016A (nl) 1976-10-20
AU510088B2 (en) 1980-06-05
IE43600L (en) 1976-10-18
JPS51131860A (en) 1976-11-16
DK142976A (da) 1976-10-19
FR2307525B1 (fr) 1980-11-28
ATA273976A (de) 1980-05-15
BE840872A (fr) 1976-10-18
GB1549047A (en) 1979-08-01
CH626876A5 (fr) 1981-12-15

Similar Documents

Publication Publication Date Title
FR2307525B1 (fr)
FR2300557B1 (fr)
JPS5625996Y2 (fr)
CH595059A5 (fr)
CH601809A5 (fr)
CH580723A5 (fr)
CH586052A5 (fr)
BG22607A1 (fr)
CH586623A5 (fr)
CH587393A5 (fr)
CH587444A5 (fr)
CH588682A5 (fr)
CH588848A5 (fr)
CH589266A5 (fr)
CH589948A5 (fr)
CH591910A5 (fr)
CH592314A5 (fr)
CH593455A5 (fr)
BG26513A3 (fr)
CH594461A5 (fr)
CH594468A5 (fr)
BG22718A1 (fr)
CH595165A5 (fr)
BG23020A1 (fr)
CH595486A5 (fr)